vs
Side-by-side financial comparison of GYRE THERAPEUTICS, INC. (GYRE) and Rumble Inc. (RUM). Click either name above to swap in a different company.
GYRE THERAPEUTICS, INC. is the larger business by last-quarter revenue ($37.2M vs $27.1M, roughly 1.4× Rumble Inc.). GYRE THERAPEUTICS, INC. runs the higher net margin — -3.7% vs -120.8%, a 117.1% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs -10.5%). GYRE THERAPEUTICS, INC. produced more free cash flow last quarter ($-5.8M vs $-31.7M). Over the past eight quarters, GYRE THERAPEUTICS, INC.'s revenue compounded faster (17.0% CAGR vs 15.2%).
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
Rumble is a Canadian-American online video platform, web hosting, and cloud services business headquartered in Toronto, Canada, with its U.S. headquarters in Longboat Key, Florida. It was founded in 2013 by Chris Pavlovski, a Canadian technology entrepreneur. Rumble's cloud services business hosts Truth Social, and the video platform is popular among American conservative and far-right users. Rumble has been described as "alt-tech".
GYRE vs RUM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $37.2M | $27.1M |
| Net Profit | $-1.4M | $-32.7M |
| Gross Margin | 95.3% | 5.5% |
| Operating Margin | 0.3% | -131.1% |
| Net Margin | -3.7% | -120.8% |
| Revenue YoY | 33.4% | -10.5% |
| Net Profit YoY | -340.1% | 86.2% |
| EPS (diluted) | $-0.01 | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $37.2M | $27.1M | ||
| Q3 25 | $30.6M | $24.8M | ||
| Q2 25 | $26.8M | — | ||
| Q1 25 | $22.1M | $23.7M | ||
| Q4 24 | $27.9M | $30.2M | ||
| Q3 24 | $25.5M | $25.1M | ||
| Q2 24 | $25.2M | $22.5M | ||
| Q1 24 | $27.2M | $17.7M |
| Q4 25 | $-1.4M | $-32.7M | ||
| Q3 25 | $5.9M | $-16.3M | ||
| Q2 25 | $1.6M | — | ||
| Q1 25 | $3.7M | $-2.7M | ||
| Q4 24 | $569.0K | $-236.8M | ||
| Q3 24 | $2.9M | $-31.5M | ||
| Q2 24 | $4.5M | $-26.8M | ||
| Q1 24 | $9.9M | $-43.3M |
| Q4 25 | 95.3% | 5.5% | ||
| Q3 25 | 94.7% | -1.8% | ||
| Q2 25 | 95.7% | — | ||
| Q1 25 | 95.9% | -26.7% | ||
| Q4 24 | 95.8% | -14.2% | ||
| Q3 24 | 96.2% | -45.4% | ||
| Q2 24 | 96.9% | -58.8% | ||
| Q1 24 | 96.4% | -79.5% |
| Q4 25 | 0.3% | -131.1% | ||
| Q3 25 | 22.7% | -113.6% | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 10.3% | -153.5% | ||
| Q4 24 | 2.4% | -80.1% | ||
| Q3 24 | 16.6% | -131.0% | ||
| Q2 24 | 12.7% | -172.7% | ||
| Q1 24 | 29.7% | -197.4% |
| Q4 25 | -3.7% | -120.8% | ||
| Q3 25 | 19.4% | -65.7% | ||
| Q2 25 | 5.9% | — | ||
| Q1 25 | 16.9% | -11.2% | ||
| Q4 24 | 2.0% | -783.2% | ||
| Q3 24 | 11.2% | -125.9% | ||
| Q2 24 | 18.0% | -119.2% | ||
| Q1 24 | 36.6% | -244.1% |
| Q4 25 | $-0.01 | $-0.13 | ||
| Q3 25 | $0.03 | $-0.06 | ||
| Q2 25 | $0.00 | — | ||
| Q1 25 | $0.00 | $-0.01 | ||
| Q4 24 | $0.00 | $-1.17 | ||
| Q3 24 | $0.01 | $-0.15 | ||
| Q2 24 | $0.01 | $-0.13 | ||
| Q1 24 | $0.03 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | $237.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $106.0M | $274.8M |
| Total Assets | $166.1M | $336.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | $237.9M | ||
| Q3 25 | $60.0M | $269.8M | ||
| Q2 25 | $54.4M | — | ||
| Q1 25 | $29.9M | $301.3M | ||
| Q4 24 | $26.7M | $114.0M | ||
| Q3 24 | $25.1M | $132.0M | ||
| Q2 24 | $25.1M | $154.2M | ||
| Q1 24 | $37.4M | $183.8M |
| Q4 25 | $106.0M | $274.8M | ||
| Q3 25 | $101.9M | $302.2M | ||
| Q2 25 | $92.0M | — | ||
| Q1 25 | $68.1M | $339.6M | ||
| Q4 24 | $63.3M | $-63.1M | ||
| Q3 24 | $63.2M | $166.1M | ||
| Q2 24 | $60.4M | $192.7M | ||
| Q1 24 | $56.6M | $210.7M |
| Q4 25 | $166.1M | $336.8M | ||
| Q3 25 | $159.4M | $367.2M | ||
| Q2 25 | $152.6M | — | ||
| Q1 25 | $129.8M | $391.1M | ||
| Q4 24 | $125.4M | $195.3M | ||
| Q3 24 | $125.2M | $217.2M | ||
| Q2 24 | $120.9M | $243.2M | ||
| Q1 24 | $122.0M | $263.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.6M | $-29.4M |
| Free Cash FlowOCF − Capex | $-5.8M | $-31.7M |
| FCF MarginFCF / Revenue | -15.5% | -117.2% |
| Capex IntensityCapex / Revenue | 0.4% | 8.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-180.0K | $-70.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.6M | $-29.4M | ||
| Q3 25 | $4.7M | $-10.6M | ||
| Q2 25 | $2.1M | — | ||
| Q1 25 | $-129.0K | $-14.5M | ||
| Q4 24 | $-2.8M | $-12.4M | ||
| Q3 24 | $1.7M | $-19.1M | ||
| Q2 24 | $-5.5M | $-21.7M | ||
| Q1 24 | $2.9M | $-33.9M |
| Q4 25 | $-5.8M | $-31.7M | ||
| Q3 25 | $4.0M | $-12.0M | ||
| Q2 25 | $1.8M | — | ||
| Q1 25 | $-251.0K | $-14.6M | ||
| Q4 24 | $-2.8M | $-12.4M | ||
| Q3 24 | $1.0M | $-19.9M | ||
| Q2 24 | $-6.9M | $-23.1M | ||
| Q1 24 | $2.7M | $-34.3M |
| Q4 25 | -15.5% | -117.2% | ||
| Q3 25 | 13.1% | -48.6% | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | -1.1% | -61.7% | ||
| Q4 24 | -10.1% | -40.9% | ||
| Q3 24 | 4.1% | -79.5% | ||
| Q2 24 | -27.5% | -102.8% | ||
| Q1 24 | 9.8% | -193.3% |
| Q4 25 | 0.4% | 8.5% | ||
| Q3 25 | 2.2% | 5.7% | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.6% | 0.6% | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 2.7% | 3.4% | ||
| Q2 24 | 5.8% | 6.1% | ||
| Q1 24 | 0.9% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 1.32× | — | ||
| Q1 25 | -0.03× | — | ||
| Q4 24 | -4.85× | — | ||
| Q3 24 | 0.60× | — | ||
| Q2 24 | -1.21× | — | ||
| Q1 24 | 0.29× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GYRE
Segment breakdown not available.
RUM
| Audience Monetization | $23.8M | 88% |
| Other Initiatives | $3.3M | 12% |
